Italy, Russia, Switzerland
RDIF calls on Italian-Swiss contacts to secure Sputnik V production
While the European Union is still divided over Russia's Sputnik V vaccine, Moscow's sovereign wealth fund is working its contacts with European pharmaceutical groups, starting with Antonio di Naro's Swiss group Adienne, with the view towards future production.


